Takeda Pharmaceutical (TAK) Total Debt (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Total Debt of $31.5 billion for Q2 2026, down 2.48% year-over-year from $32.3 billion in Q2 2025, and little changed quarter-over-quarter from $31.5 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Total Debt (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Total Debt history runs 9 years deep, the most recent figure standing at $31.5 billion for Q2 2026.
- In Q2 2026, Total Debt fell 2.48% year-over-year to $31.5 billion; the TTM figure through Jun 2026 stood at $31.5 billion (down 2.48% YoY), while the FY2026 annual figure was $32.8 billion, up 10.73% from the prior year.
- Total Debt for Q2 2026 stood at $31.5 billion, roughly flat from $31.5 billion in the prior quarter.
- The five-year high for Total Debt was $37.4 billion in Q1 2022, with the low at $6.6 billion in Q1 2023.
- The 5-year median for Total Debt is $33.0 billion (2023), against an average of $30.6 billion.
- The sharpest annual moves came in 2022 and 2023: Total Debt soared 416.87% in 2022, then sank 82.33% in 2023.
- Takeda Pharmaceutical's Total Debt stood at $31.3 billion in 2022, then grew by 4.61% to $32.7 billion in 2023, then gained by 6.47% to $34.8 billion in 2024, then retreated by 9.74% to $31.4 billion in 2025, then grew by 0.1% to $31.5 billion in 2026.
- Business Quant data shows TAK's Total Debt at $31.5 billion in Q2 2026, $31.5 billion in Q1 2026, and $31.4 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.47 Bn |
| Mar 31, 2026 | 31.51 Bn |
| Dec 31, 2025 | 31.44 Bn |
| Sep 30, 2025 | 33.24 Bn |
| Jun 30, 2025 | 32.27 Bn |
| Mar 31, 2025 | 29.60 Bn |
| Dec 31, 2024 | 34.83 Bn |
| Sep 30, 2024 | 33.42 Bn |
| Jun 30, 2024 | 36.35 Bn |
| Mar 31, 2024 | 7.12 Bn |
| Dec 31, 2023 | 32.72 Bn |
| Sep 30, 2023 | 34.48 Bn |
| Jun 30, 2023 | 35.21 Bn |
| Mar 31, 2023 | 6.61 Bn |
| Dec 31, 2022 | 31.28 Bn |
| Sep 30, 2022 | 34.15 Bn |
| Jun 30, 2022 | 37.34 Bn |
| Mar 31, 2022 | 37.39 Bn |
| Dec 31, 2021 | 41.29 Bn |
| Sep 30, 2021 | 40.71 Bn |